These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9087489)

  • 1. Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.
    Fuursted K; Knudsen JD; Petersen MB; Poulsen RL; Rehm D
    Antimicrob Agents Chemother; 1997 Apr; 41(4):781-4. PubMed ID: 9087489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
    Ednie LM; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities.
    Poulsen RL; Knudsen JD; Petersen MB; Fuursted K; Espersen F; Frimodt-Møller N
    APMIS; 1996 Mar; 104(3):227-33. PubMed ID: 8611198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Mar; 42(3):624-30. PubMed ID: 9517943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
    Visalli MA; Jacobs MR; Appelbaum PC
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipneumococcal activity of ABT-773 compared to those of 10 other agents.
    Davies TA; Ednie LM; Hoellman DM; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1894-9. PubMed ID: 10858350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
    Spangler SK; Lin G; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 May; 42(5):1253-5. PubMed ID: 9593160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
    Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
    Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1033-6. PubMed ID: 9145864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2065-72. PubMed ID: 7811020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.
    Spangler SK; Lin G; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2173-6. PubMed ID: 9333043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria.
    Minguez F; Ramos C; Loscos A; Chiu ML; Prieto J
    Chemotherapy; 1993; 39(3):163-8. PubMed ID: 8389685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
    Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
    Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
    Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.